We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Enterprise-Grade Digital Stethoscope Platform Brings Non-Invasive Heart Disease Detection to Primary Care

By HospiMedica International staff writers
Posted on 28 Feb 2023

Valvular heart disease (VHD) can be life-threatening if left undiagnosed and untreated, resulting in heart failure, stroke, blood clots, and death. More...

Adults over the age of 65 have a one in ten chance of developing clinically significant VHD, yet more than half (57%) of these cases go undetected. Now, a cardiovascular disease detection platform combines the latest advancements in applied machine learning with one of the most ubiquitous medical devices in the world: the stethoscope to objectively identify structural murmurs, a sign of VHD.

Eko (Oakland, CA, USA) has unveiled the SENSORA Cardiac Disease Detection Platform, which uses artificial intelligence to identify structural murmurs, as well as Care Pathway Analytics software to provide visibility and metrics of the patient's progress through the healthcare system. Eko achieved this by capturing and analyzing heart sounds and electrical signals with its digital stethoscopes. The use of this detection platform is set to expand further as the company develops applications for other cardiac issues.

The SENSORA FDA-cleared structural murmur detection helps health systems accurately and consistently identify VHD in patients during a routine visit to a primary care physician. When a primary care physician uses this platform for structural murmur detection, their likelihood of detecting a significant VHD in an older patient more than doubles. Additionally, SENSORA's Care Pathway Analytics allows for better follow up with patients identified with structural murmurs, offering downstream visibility into patient flows, clinical outcomes, and patient economics. By assisting with key decision-making, such as identifying care gaps, SENSORA helps to improve operational efficiencies, reduce delays in delivery of care, reduce the length of stay, lower readmission rates, and increase patient and physician satisfaction.

"Our vision for SENSORA is to make cardiovascular disease detection simple and accurate in frontline care settings like primary care and urgent care," said Connor Landgraf, Co-founder & CEO of Eko. "During a routine physical exam, patients can now have access to advanced structural murmur detection and arrhythmia assessment by their primary care physician in seconds, making early intervention possible for millions of patients with silent cardiovascular disease. We are making the world's most universal medical exam objective and accurate."

Related Links:
Eko 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infrared Digital Thermometer
R1B1
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.